Wednesday - July 29, 2026
Clinical Trial: Daily Use of FDA-Approved CBD Formulation Increases BMI in Anorexia Patients
April 02, 2026
WASHINGTON, April 2 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:

* * *

Clinical Trial: Daily Use of FDA-Approved CBD Formulation Increases BMI in Anorexia Patients

*

Los Angeles, CA: The use of an FDA-approved, plant-derived formulation of CBD (Epidiolex) stimulates weight gain in patients with anorexia nervosa (AN), according to randomized, placebo-controlled clinical . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products